• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
2
More Use of Peritoneal Dialysis Gives Significant Savings: A Systematic Review and Health Economic Decision Model.更多地使用腹膜透析可带来显著的成本节约:一项系统评价与卫生经济决策模型
J Clin Med Res. 2017 Feb;9(2):104-116. doi: 10.14740/jocmr2817w. Epub 2016 Dec 31.
3
Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.腹膜透析优先政策下终末期肾病患者一线透析方式的终身成本效益分析
BMC Nephrol. 2020 Feb 4;21(1):42. doi: 10.1186/s12882-020-1708-0.
4
5
Comparing Renal Replacement Therapy Modalities in Critically Ill Patients With Acute Kidney Injury: A Systematic Review and Network Meta-Analysis.比较急性肾损伤重症患者的肾脏替代治疗方式:一项系统评价和网状Meta分析
Crit Care Explor. 2021 May 12;3(5):e0399. doi: 10.1097/CCE.0000000000000399. eCollection 2021 May.
6
Cost-Effectiveness of Home Hemodialysis With Bedside Portable Dialysis Machine "DIMI" in the United Arab Emirates.阿拉伯联合酋长国使用床边便携式透析机“DIMI”进行家庭血液透析的成本效益
Cureus. 2021 Oct 6;13(10):e18549. doi: 10.7759/cureus.18549. eCollection 2021 Oct.
7
Cost analysis of dialysis treatments for end-stage renal disease (ESRD).终末期肾病(ESRD)透析治疗的成本分析。
Clin Invest Med. 1995 Dec;18(6):455-64.
8
Cost Effectiveness of Dialysis Modalities: A Systematic Review of Economic Evaluations.透析模式的成本效益:经济评估的系统综述。
Appl Health Econ Health Policy. 2019 Jun;17(3):315-330. doi: 10.1007/s40258-018-00455-2.
9
Cost of Dialysis Therapy by Modality in Manitoba.曼尼托巴省不同透析方式的治疗费用。
Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1197-1203. doi: 10.2215/CJN.10180917. Epub 2018 Jul 18.
10
An economic evaluation of hospital-based hemodialysis and home-based peritoneal dialysis for pediatric patients.针对儿科患者的医院血液透析和家庭腹膜透析的经济学评估。
Am J Kidney Dis. 1996 Apr;27(4):557-65. doi: 10.1016/s0272-6386(96)90167-5.

PMID:29320086
Abstract

During the last ten years, the number of dialysis patients has doubled in Norway. After a request from The Norwegian Directorate of Health we performed a Health Technology Assessment comparing efficacy, safety and cost-effectiveness of the different dialysis modalities 1) Hemodialysis carried out in hospital, 2) self-care hemodialysis in hospital, 3) hemodialysis in satellite unit (nursing home, local medical centre), 4) hemodialysis at home and 5) peritoneal dialysis at home for patients with end-stage renal failure requiring dialysis in Norway. Our outcomes were mortality, complications that require special measures and quality of life. Of 21 possible comparisons only six had published data. For the comparisons with published data and low quality of the evidence, we found: no significant differences in mortality, in quality of life or in infections; significantly fewer hospitalisation days per patients per year in the hemodialysis hospital group versus the peritoneal dialysis at home group. In our model analyses all dialysis modalities were almost equally effective. Hemodialysis at home was the most effective and cost-effective alternative compared to all other hemodialysis modalities from both healthcare and societal perspectives. Peritoneal dialysis was the least costly, and hence the most cost-effective alternative compared to all hemodialysis modalities. The results of our sensitivity analysis showed that cost data had the greatest impact on the results’ uncertainty.

摘要